Similarly, Bharti et al.37 found that CD55 promotes chemoresistance and the increase of cancer stem cells by activating ROR2/JNK signaling and upregulating SOX2, Nanog, and OCT4 expression in endometrioid ovarian cancer. This evidence concerns the gene CD55 and ovarian endometrioid adenocarcinoma.